Key Points
- Director Teresa Deluca purchased 10,000 Surgery Partners shares at an average price of $14.35, investing $143,500 and increasing her direct holdings by 17.59% to 66,843 shares.
- Surgery Partners shares opened at $13.60 after falling 4.5%; the stock has traded between $11.41 and $24.10 over the past year.
- The company beat quarterly estimates with EPS of $0.10 versus $0.06 expected and revenue of $848.9 million, up 2.7% year over year. Analysts maintain a “Moderate Buy” consensus with an average price target of $19.45.
Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) Director Teresa Deluca bought 10,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were bought at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the purchase, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Surgery Partners Trading Down 4.5%
Surgery Partners stock opened at $13.60 on Thursday. The business has a 50-day simple moving average of $15.61 and a two-hundred day simple moving average of $14.39. The company has a market cap of $1.78 billion, a P/E ratio of -19.43, a P/E/G ratio of 3.86 and a beta of 1.91. Surgery Partners, Inc. has a 52-week low of $11.41 and a 52-week high of $24.10. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.04. The company had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The firm's revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.17 EPS. Analysts predict that Surgery Partners, Inc. will post 0.25 EPS for the current year.
Analyst Ratings Changes
SGRY has been the topic of a number of research reports. Raymond James Financial set a $18.00 price objective on Surgery Partners in a research note on Tuesday, August 11th. Benchmark reiterated a "buy" rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Jefferies Financial Group reissued a "buy" rating and issued a $17.00 target price on shares of Surgery Partners in a report on Wednesday, May 6th. Cantor Fitzgerald restated an "overweight" rating and issued a $18.00 price target on shares of Surgery Partners in a research report on Tuesday, August 11th. Finally, Royal Bank Of Canada decreased their price target on shares of Surgery Partners from $20.00 to $19.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 11th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $19.45.
Get Our Latest Analysis on SGRY
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. PNC Financial Services Group Inc. lifted its stake in shares of Surgery Partners by 239.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company's stock worth $35,000 after acquiring an additional 2,051 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in Surgery Partners in the second quarter worth $38,000. Fifth Third Bancorp lifted its position in shares of Surgery Partners by 5,324.0% during the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company's stock worth $48,000 after purchasing an additional 3,993 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Surgery Partners by 45,640.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company's stock worth $49,000 after purchasing an additional 2,282 shares during the last quarter. Finally, Aquatic Capital Management LLC purchased a new stake in shares of Surgery Partners during the third quarter valued at $121,000.
Surgery Partners Company Profile
(
Get Free Report)
Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.
Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
